Article
Impact of Switching Vicodin, Norco, Lortab to Schedule II
RxEconsult, LLC
ORCiD
Adam M. Kaye: 0000-0002-7224-3322
Document Type
Blog Post
Publication Date
1-28-2013
Disciplines
Abstract
On January 25, 2013 an FDA advisory panel of experts voted 19 to 10 to change hydrocodone containing products from schedule III controlled drugs to the more restricted schedule II controlled substance category. The FDA is expected to adopt this recommendations despite strong opposition from several groups. Hydrocodone medications include Vicodin, Lortab, Norco, and generic versions.
Citation Information
Adam M. Kaye. "Impact of Switching Vicodin, Norco, Lortab to Schedule II" RxEconsult, LLC (2013) Available at: http://works.bepress.com/adam-kaye/199/